1. Home
  2. UNCY vs OMEX Comparison

UNCY vs OMEX Comparison

Compare UNCY & OMEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UNCY
  • OMEX
  • Stock Information
  • Founded
  • UNCY 2016
  • OMEX 1986
  • Country
  • UNCY United States
  • OMEX United States
  • Employees
  • UNCY N/A
  • OMEX N/A
  • Industry
  • UNCY Biotechnology: Pharmaceutical Preparations
  • OMEX Marine Transportation
  • Sector
  • UNCY Health Care
  • OMEX Consumer Discretionary
  • Exchange
  • UNCY Nasdaq
  • OMEX Nasdaq
  • Market Cap
  • UNCY 74.2M
  • OMEX 82.2M
  • IPO Year
  • UNCY 2021
  • OMEX N/A
  • Fundamental
  • Price
  • UNCY $4.93
  • OMEX $3.25
  • Analyst Decision
  • UNCY Strong Buy
  • OMEX
  • Analyst Count
  • UNCY 5
  • OMEX 0
  • Target Price
  • UNCY $55.20
  • OMEX N/A
  • AVG Volume (30 Days)
  • UNCY 419.1K
  • OMEX 4.0M
  • Earning Date
  • UNCY 11-12-2025
  • OMEX 11-12-2025
  • Dividend Yield
  • UNCY N/A
  • OMEX N/A
  • EPS Growth
  • UNCY N/A
  • OMEX N/A
  • EPS
  • UNCY N/A
  • OMEX N/A
  • Revenue
  • UNCY N/A
  • OMEX $620,048.00
  • Revenue This Year
  • UNCY N/A
  • OMEX N/A
  • Revenue Next Year
  • UNCY $19,912.34
  • OMEX N/A
  • P/E Ratio
  • UNCY N/A
  • OMEX $151.53
  • Revenue Growth
  • UNCY N/A
  • OMEX N/A
  • 52 Week Low
  • UNCY $3.71
  • OMEX $0.27
  • 52 Week High
  • UNCY $11.00
  • OMEX $4.43
  • Technical
  • Relative Strength Index (RSI)
  • UNCY 66.90
  • OMEX 62.14
  • Support Level
  • UNCY $4.33
  • OMEX $2.78
  • Resistance Level
  • UNCY $4.81
  • OMEX $4.43
  • Average True Range (ATR)
  • UNCY 0.31
  • OMEX 0.42
  • MACD
  • UNCY 0.04
  • OMEX 0.12
  • Stochastic Oscillator
  • UNCY 70.07
  • OMEX 53.73

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.

About OMEX Odyssey Marine Exploration Inc.

Odyssey Marine Exploration Inc is a deep-ocean exploration company. The company provides specialized mineral exploration, project development, and marine services to clients. It is engaged in the discovery, validation, and development of subsea mineral deposits in a socially and environmentally responsible manner. The company works with governments to identify mineral resources in Exclusive Economic Zones, focusing on phosphorite (fertilizer) and polymetallic nodules (battery metals) projects. Its projects include the ExO Phosphate project, CIC, Ocean Minerals, and the LIHIR Gold project.

Share on Social Networks: